Covered recipient · General Payments record
PAMELA J RIZZA
Allopathic & Osteopathic Physicians Family Medicine Sports Medicine
General Payments · PY2018–2019
$424.50
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2019 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $122.45 | 10 |
By paying entity
PY2019 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $26.33 | 2 |
| GlaxoSmithKline, LLC. | $26.07 | 2 |
| Amgen Inc. | $22.65 | 2 |
| ADVANCED RESPIRATORY, INC | $12.60 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $12.20 | 1 |
| Mylan Specialty L.P. | $11.79 | 1 |
| Acerta Pharma LLC | $10.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2019 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ADVANCED RESPIRATORY, INC | $12.60 | 11/13/2019 | Food and Beverage | Undisputed | 01/23/2026 | 706299007 | CMS |
| Amgen Inc. | $10.82 | 03/20/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662847427 | CMS |
| Amgen Inc. | $11.83 | 04/24/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662847425 | CMS |
| AstraZeneca Pharmaceuticals LP | $10.81 | 08/14/2019 | Food and Beverage | Undisputed | 01/23/2026 | 685249271 | CMS |
| GlaxoSmithKline, LLC. | $13.35 | 02/14/2019 | Food and Beverage | Undisputed | 01/23/2026 | 671439917 | CMS |
| GlaxoSmithKline, LLC. | $12.72 | 04/04/2019 | Food and Beverage | Undisputed | 01/23/2026 | 671397229 | CMS |
| Mylan Specialty L.P. | $11.79 | 03/01/2019 | Food and Beverage | Undisputed | 01/23/2026 | 694777863 | CMS |
| Novo Nordisk Inc | $12.87 | 02/11/2019 | Food and Beverage | Undisputed | 01/23/2026 | 668787507 | CMS |
| Novo Nordisk Inc | $13.46 | 06/26/2019 | Food and Beverage | Undisputed | 01/23/2026 | 674435953 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $12.20 | 03/22/2019 | Food and Beverage | Undisputed | 01/23/2026 | 681920215 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019
- Source files
- Dataset page · Bulk file · PY2018 , PY2019
- Generated from
- OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.